Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nilesh Pandey

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Microbial Pathogenesis|August 20, 2021
Influence of TLR4 and TLR9 polymorphisms and haplotypes on multiple hrHPV infections and HPV16 copy number in cervical cancer and cervicitisNilesh Pandey, Alex Chauhan, Nitin Raithatha, et al.
Plos One|August 1, 2019
Association of TLR4 and TLR9 gene polymorphisms and haplotypes with cervicitis susceptibilityAlex Chauhan, Nilesh Pandey, Ajesh Desai, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
CD14 Blockade Does Not Improve Outcomes of Deep Vein Thrombosis Following Inferior Vena Cava Stenosis in MiceNilesh Pandey, Harpreet Kaur, Lakshmi Chandaluri, et al.
Journal of Thrombosis and Haemostasis : JTH|September 21, 2024
Enhanced venous thrombosis and hypercoagulability in murine and human metabolic dysfunction-associated steatohepatitisNilesh Pandey, Sumit Kumar Anand, Harpreet Kaur, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 31, 2025
Neutrophil Integrin α9 Impairs Efferocytosis and Worsens Long-Term Recovery After Subarachnoid HemorrhageHarpreet Kaur, Nilesh Pandey, Lakshmi Chandaluri, et al.
Blood Advances|March 18, 2024
Interactions between integrin α9β1 and VCAM-1 promote neutrophil hyperactivation and mediate poststroke DVTNilesh Pandey, Harpreet Kaur, Mehul R Chorawala, et al.
Blood Advances|January 9, 2026
Neutrophil CD14 is a Driver and a Therapeutic Target for Deep Vein ThrombosisNilesh Pandey, Harpreet Kaur, Raktim Mitra, et al.
Experimental Neurology|February 6, 2025
Prolyl hydroxylase inhibitor desidustat improves stroke outcomes via enhancing efferocytosis in mice with chronic kidney diseaseHarpreet Kaur, Nilesh Pandey, Lakshmi Chandaluri, et al.
Journal of Medicinal Chemistry|January 2, 2026
Targeting Oxalate Production by Combining Enzyme Inhibition and Proteolysis Activation: A Novel Therapeutic Approach for Primary Hyperoxaluria Type 1Fabio Arias, Sumati Rohilla, Yudibeth Sixto-López, et al.
JHEP Reports : Innovation in Hepatology|March 4, 2026
Sex-based multiomics analysis uncovers metabolic and molecular mediators linking MASH and atherosclerosisSandeep Das, Sumit Kumar Anand, M Peyton McKinney, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Microbial Pathogenesis|August 20, 2021
Influence of TLR4 and TLR9 polymorphisms and haplotypes on multiple hrHPV infections and HPV16 copy number in cervical cancer and cervicitisNilesh Pandey, Alex Chauhan, Nitin Raithatha, et al.
Plos One|August 1, 2019
Association of TLR4 and TLR9 gene polymorphisms and haplotypes with cervicitis susceptibilityAlex Chauhan, Nilesh Pandey, Ajesh Desai, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
CD14 Blockade Does Not Improve Outcomes of Deep Vein Thrombosis Following Inferior Vena Cava Stenosis in MiceNilesh Pandey, Harpreet Kaur, Lakshmi Chandaluri, et al.
Journal of Thrombosis and Haemostasis : JTH|September 21, 2024
Enhanced venous thrombosis and hypercoagulability in murine and human metabolic dysfunction-associated steatohepatitisNilesh Pandey, Sumit Kumar Anand, Harpreet Kaur, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 31, 2025
Neutrophil Integrin α9 Impairs Efferocytosis and Worsens Long-Term Recovery After Subarachnoid HemorrhageHarpreet Kaur, Nilesh Pandey, Lakshmi Chandaluri, et al.
Blood Advances|March 18, 2024
Interactions between integrin α9β1 and VCAM-1 promote neutrophil hyperactivation and mediate poststroke DVTNilesh Pandey, Harpreet Kaur, Mehul R Chorawala, et al.
Blood Advances|January 9, 2026
Neutrophil CD14 is a Driver and a Therapeutic Target for Deep Vein ThrombosisNilesh Pandey, Harpreet Kaur, Raktim Mitra, et al.
Experimental Neurology|February 6, 2025
Prolyl hydroxylase inhibitor desidustat improves stroke outcomes via enhancing efferocytosis in mice with chronic kidney diseaseHarpreet Kaur, Nilesh Pandey, Lakshmi Chandaluri, et al.
Journal of Medicinal Chemistry|January 2, 2026
Targeting Oxalate Production by Combining Enzyme Inhibition and Proteolysis Activation: A Novel Therapeutic Approach for Primary Hyperoxaluria Type 1Fabio Arias, Sumati Rohilla, Yudibeth Sixto-López, et al.
JHEP Reports : Innovation in Hepatology|March 4, 2026
Sex-based multiomics analysis uncovers metabolic and molecular mediators linking MASH and atherosclerosisSandeep Das, Sumit Kumar Anand, M Peyton McKinney, et al.
Pageof 3